Navigation Links
Nuvo announces second quarter 2008 financial results
Date:7/31/2008

dian Pennsaid sales and an

additional $2.0 million through the issuance of a convertible

debenture. These transactions extend the Company's cash financial

runway beyond mid 2009 when it expects to receive U.S. FDA approval of

Pennsaid, a topical non-steroidal anti-inflammatory drug (NSAID) used

to treat the pain and stiffness associated with knee osteoarthritis.

"Quarter by quarter, we are steadily moving closer to our goal of achieving Pennsaid's approval in the U.S., while ensuring we have suitable cash resources beyond this milestone," said Henrich Guntermann, President and Chief Executive Officer, "At the same time, we are excited about our expanding pipeline, which we strengthened in the second quarter through internal research and development activities and by our agreement to in-license the exclusive rights to develop and commercialize a novel, early stage topical pain formulation."

Financial Results

(thousands of Three months Three months Six months Six months

Canadian dollars) ended ended ended ended

June 30, June 30, June 30, June 30,

2008 2007 2008 2007

-------------------------------------------------------------------------

Revenue $ 2,085 $ 1,435 $ 4,321 $ 2,413

Net loss $ (2,864) $ (3,034) $ (5,135) $ (6,521)

-------------------------------------------------------------------------

Revenue for the three-months ended June 30, 2008 increased 45% to $2.1 million compared with $1.4 million for the three-months ended June 30, 2007. The significant increase is due primarily to a $0.6 million increase in Pennsaid product sales to the Company's Greek distributor and an increase in sales of WF10 based products. Revenue for the six-months ended June 30, 2008 inc
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
2. Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
3. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
4. Hologic Announces Third Quarter Fiscal 2008 Operating Results
5. VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives
6. The Quantum Group Announces 2nd Statewide Contract
7. STERIS Corporation Announces Fiscal 2009 First Quarter Results
8. CutisPharma Announces Strategic Collaboration with Rite Aid Corporation
9. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
10. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
11. Align Technology Announces Second Quarter Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Spain Monday 1 September 2014: Permanent atrial fibrillation ... AF, according to research in more than 6 000 ... Vanassche from Belgium. The findings suggest that a simple ... doctors to better estimate stroke risk. , Ischaemic stroke ... accounting for over a million deaths and many more ...
(Date:9/1/2014)... 01, 2014 Bioinformatics refers to ... analyze biological and genetic data. A major part ... developing software tools to generate and process useful ... with biological computation. While bioinformatics simply makes use ... can its related concepts, biological computation refers to ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web ... carefully, Top10BestSEOHosting.com is here to announce that JustHost, ... suppliers in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) ... shared hosting plan. The company’s approach to hosting ... affordable, accessible and powerful enough for anyone to ...
(Date:9/1/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on DePuy Synthes Craniomaxillofacial ... on August 28, that specific lots of DePuy Synthes ... as the device may reverse directions after surgery. ... Distraction System is an implant used to lengthen and/or ...
(Date:9/1/2014)... Psychogenic Non-epileptic Seizures (PNES), also known as ... can have devastating effects on those who develop it. ... they are not produced by electrical anomalies in the ... estimated that the numbers of persons suffering PNES may ... , Dr. Lorna Myers, Director of the Northeast ...
Breaking Medicine News(10 mins):Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:The Northeast Regional Epilepsy Group (NEREG) Offers First Conference on Psychogenic Non-epileptic Seizures (PNES) on September 20, 2014 in New Jersey 2
... For the first time researchers have found out what effect ... on healthy individuals. , The results of a diet study ... blood lipids by 14 per cent, blood pressure by 8 ... 26 per cent. A marker of inflammation in the body ...
... has reached out to Michigan State University to inform ... environmental chemicals and help them access appropriate guidelines on ... MSU researchers Ken Rosenman, Gary Ferenchick and David Solomon ... and Kari Hortos from the College of Osteopathic Medicine ...
... has announced plans to award Dr. Emily Tobey of ... her pioneering research and academic leadership. Tobey ... in the School of Behavioral and Brain Sciences (BBS) ... Center for Communication Disorders. In selecting her for its ...
... Julia Vantine HealthDay Reporter , THURSDAY, ... depression that uses intense magnetic pulses to stimulate the ... periods, appears to work over the longer term when ... address the question of whether the benefit of TMS ...
... prodigious precursors of all the tissues in our body, ... unfortunately, cancer. Now research from Rockefeller University shows that ... live for too long, can increase the odds of ... cell death in precursor cells for blood, or hematopoietic ...
... HealthDay Reporter , THURSDAY, Oct. 14 (HealthDay ... need for adults to be vaccinated against this highly ... only does vaccination protect adults against the disease, it ... illness that can be life-threatening to those most at ...
Cached Medicine News:Health News:MSU tasked with educating health-care providers on fish consumption 2Health News:Award to honor pivotal career in speech research 2Health News:Award to honor pivotal career in speech research 3Health News:Magnet Therapy an Option for Tough-to-Treat Depression 2Health News:Magnet Therapy an Option for Tough-to-Treat Depression 3Health News:Gene identified that prevents stem cells from turning cancerous 2Health News:Gene identified that prevents stem cells from turning cancerous 3Health News:Too Few Adults Vaccinated Against Whooping Cough: CDC 2
(Date:8/29/2014)... 29, 2014  A Boston Scientific Corporation (NYSE: ... stent removability and preliminary long term stricture resolution ... the August issue of the peer-reviewed journal, Gastroenterology. ... is being conducted in 11 countries and five ... metal stents (FCSEMS) after extended indwell (i.e., up ...
(Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in the 2014 Morgan Stanley Global Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... methods developed to prevent and eradicate the prevalence of ... methods are confined to low specificity, safety and large ... look for a better solution. It has been discovered ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2
The Thermal pads were designed to simulate water immersion, the most effective method of transferring energy non-invasively....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Medicine Products: